BICR 3 Cell Line
Invented by Prof Eric Kenneth Parkinson from Queen Mary University of London
Invented at Cancer Research UK Glasgow: The Beatson Institute
- Datasheet
- References (2)
- Inventor Info
Info
Catalogue Number | 152845 |
Host | Human |
Tissue | Alveolus |
Disease Keywords | Alveolus squamous cell carcinoma |
Model | Tumour line |
Relevance | Adherent keratinocyte cell line derived from a squamous cell carcinoma of the alveolus of a Caucasian female. Keratin and involucrin markers present. Known mutations: p53 and p16. Cells are tumourigenic in athymic mice. Epidermal Growth Factor Receptor (EGFR) present. |
Research Area | Apoptosis and Programmed Cell Death, Cancer, Drug Discovery & Development, Epigenetics & Nuclear Signalling |
Growth/Phenotype Keywords | Adherent |
Recommended Growing Conditions | DMEM + 2mM Glutamine + 10% Foetal Bovine Serum (FBS) + 0.4 micrograms/ml Hydrocortisone. |
Notes |
STR-PCR Data: Amelogenin: X, X CSF1PO: 11,12 D13S317: 8,13 D16S539: 11 D5S818: 11,12 D7S820: 10,13 THO1: 6,7 TPOX: 8 vWA: 14,19 |
Cellosaurus ID | CVCL_2311 |
References: 2 entries
Edington et al. 1995. Mol Carcinog. 13(4):254-65. PMID: 7646764.
Cellular immortality: a late event in the progression of human squamous cell carcinoma of the head and neck associated with p53 alteration and a high frequency of allele loss.
Europe PMC ID: 7646764
Add a reference
References: 2 entries
Edington et al. 1995. Mol Carcinog. 13(4):254-65. PMID: 7646764.
Cellular immortality: a late event in the progression of human squamous cell carcinoma of the head and neck associated with p53 alteration and a high frequency of allele loss.
Add a reference